Please provide your email address to receive an email when new articles are posted on . Common genetic variants do not appear to play an important role in predicting acute exacerbations of COPD or ...

Chronic obstructive pulmonary disease (COPD) management should take into account patients’ comorbidities, according to a poster presented at the Academy of Managed Care Pharmacy Nexus 2021 meeting.

telemedicine Researchers examined the risks for pneumonia and exacerbation of COPD after PPI treatment for GERD. The risk for symptom exacerbation reduced after PPI treatment for patients with GERD ...

A Chinese Phase IIb trial of the mAb has already started, with Mabwell also hoping to initiate a Phase IIa trial in the US.

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Inhaled triple ...

In a retrospective analysis of patients with chronic obstructive pulmonary disease (COPD), those whose exacerbations were treated with systemic corticosteroids alone, or together with antibiotics, did ...

Which therapy more effectively reduces severe COPD exacerbations: once-daily FF/UMEC/VI or twice-daily ICS/LABA? Treatment with once-daily single-inhaler fluticasone ...

COPD x-ray The 12-month history of acute exacerbations used to guide most COPD treatment relies on an unstable frequent exacerbator phenotype. The 12-month history of acute exacerbations used to guide ...

—The use of antibiotics in combination with oral corticosteroids to treat patients with mild-to-moderate exacerbations of COPD is the subject of much clinical debate. Reviewed by Ware Kuschner, MD, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. COPD exacerbations went down by 51% in patients with ...

Am J Health Syst Pharm. 2010;67(13):1061-1069. Considering all of the data and their limitations, questions still remain regarding the optimal treatment of COPD exacerbations. The data of deJong et al ...

Chronic obstructive pulmonary disease (COPD) is a long-term lung disease affecting at least 15 million American adults. It’s also the fourth leading cause of disease-attributed death. This makes ...